TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
VRCA

Verrica Pharmaceuticals Inc

Healthcare · Biotechnology

4.40$ -3.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Verrica Pharmaceuticals Inc (VRCA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 36 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VRCA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
97 82 66 52 33 54 42 39 41 47 39 36
92 78 61 47 28 51 39 37 36 43 33 33
84 70 49 32 23 46 30 15 21 30 21 11
84 70 49 32 23 46 30 15 21 30 21 11
4.1 4.4 7.6 10 0.1 0.1 5.7 17 7.3 5.4 7.8 11
0.3 1.0 2.5 2.7 2.6 2.5 2.5 2.5 2.3 2.2 2.0 2.7
55 62 65 65 67 64 61 57 58 22 23 32
11 17 19 20 21 29 29 29 29 16 16 22
0.3 0.7 1.0 1.1 1.2 14 13 13 13 0.7 0.7 1.0
1.9 2.5 2.5 1.2 1.0 1.9 1.4 2.3 1.6 2.1 2.2 1.6
42 43 43 43 43 31 28 25 22 – – –
42 20 1.5 -13 -34 -9.9 -19 -17 -17 25 16 4.3
-206 -230 -251 -268 -291 -307 -317 -317 -317 -325 -335 -348
4.6 4.6 4.6 4.7 4.7 6.7 9.5 9.5 9.5 11 21 21

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?